Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
NCT03788746
·
clinicaltrials.gov ↗
COMPLETED
Status
181
Enrollment
INDUSTRY
Sponsor class
Conditions
Urothelial Carcinoma
Sponsor
AstraZeneca